CME Group Inc (NASDAQ:CME) Position Decreased by FineMark National Bank & Trust

FineMark National Bank & Trust decreased its position in CME Group Inc (NASDAQ:CME) by 9.8% during the 2nd quarter, according to the company …

CME Group logoFineMark National Bank & Trust decreased its position in CME Group Inc (NASDAQ:CME) by 9.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,168 shares of the financial services provider’s stock after selling 3,181 shares during the period. FineMark National Bank & Trust’s holdings in CME Group were worth $5,662,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the company. Parnassus Investments CA purchased a new stake in CME Group during the second quarter worth about $544,292,000. Janus Henderson Group PLC boosted its holdings in CME Group by 10.7% during the first quarter. Janus Henderson Group PLC now owns 6,229,661 shares of the financial services provider’s stock worth $1,025,278,000 after buying an additional 603,645 shares in the last quarter. Geode Capital Management LLC boosted its holdings in CME Group by 12.9% during the fourth quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after buying an additional 537,917 shares in the last quarter. FMR LLC boosted its holdings in CME Group by 5.7% during the first quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock worth $1,078,600,000 after buying an additional 355,566 shares in the last quarter. Finally, AKO Capital LLP boosted its holdings in CME Group by 54.6% during the second quarter. AKO Capital LLP now owns 935,264 shares of the financial services provider’s stock worth $181,544,000 after buying an additional 330,305 shares in the last quarter. 84.99% of the stock is currently owned by institutional investors and hedge funds.

In other news, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the completion of the sale, the chief executive officer now owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total transaction of $503,250.00. Following the completion of the sale, the chief financial officer now directly owns 32,854 shares of the company’s stock, valued at approximately $6,613,510.20. The disclosure for this sale can be found here. Insiders have sold 59,626 shares of company stock valued at $12,255,934 in the last ninety days. 1.20% of the stock is currently owned by company insiders.

CME has been the topic of a number of research analyst reports. UBS Group boosted their price objective on shares of CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a report on Thursday, September 5th. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target on the stock. in a report on Monday, May 27th. Barclays upped their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday, May 23rd. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Wells Fargo & Co upped their price target on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a report on Wednesday, July 3rd. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $196.85.

Shares of NASDAQ:CME traded up $0.42 during trading on Friday, reaching $205.80. The stock had a trading volume of 974,804 shares, compared to its average volume of 1,132,937. CME Group Inc has a fifty-two week low of $161.05 and a fifty-two week high of $224.91. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The business has a fifty day moving average price of $211.25 and a 200-day moving average price of $191.16. The stock has a market cap of $72.54 billion, a P/E ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, topping the consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the business posted $1.74 earnings per share. CME Group’s revenue for the quarter was up 20.1% compared to the same quarter last year. As a group, equities analysts forecast that CME Group Inc will post 6.69 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.46%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: What causes a yield curve to invert?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

CME Group (NASDAQ:CME) Given New $214.00 Price Target at UBS Group

CME Group (NASDAQ:CME) had its price objective increased by UBS Group from $191.00 to $214.00 in a report issued on Thursday, September 5th, …

CME Group Inc logoCME Group (NASDAQ:CME) had its price objective increased by UBS Group from $191.00 to $214.00 in a report issued on Thursday, September 5th, BenzingaRatingsTable reports. The brokerage currently has a neutral rating on the financial services provider’s stock.

A number of other research analysts also recently commented on CME. Wells Fargo & Co increased their price objective on CME Group from $176.00 to $200.00 and gave the company a market perform rating in a report on Wednesday, July 3rd. Zacks Investment Research downgraded CME Group from a hold rating to a sell rating and set a $158.00 price objective on the stock. in a report on Monday, May 27th. ValuEngine upgraded CME Group from a hold rating to a buy rating in a report on Wednesday, May 8th. Deutsche Bank increased their price objective on CME Group from $224.00 to $240.00 and gave the company a buy rating in a report on Friday, August 9th. Finally, BidaskClub upgraded CME Group from a hold rating to a buy rating in a report on Friday, August 9th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of $196.85.

CME traded up $0.42 during mid-day trading on Thursday, hitting $205.80. 974,804 shares of the stock were exchanged, compared to its average volume of 1,132,937. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. The company has a market cap of $72.54 billion, a PE ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19. The firm’s fifty day moving average is $211.25 and its two-hundred day moving average is $191.16. CME Group has a 1-year low of $161.05 and a 1-year high of $224.91.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the company earned $1.74 EPS. CME Group’s revenue for the quarter was up 20.1% compared to the same quarter last year. As a group, research analysts anticipate that CME Group will post 6.69 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 annualized dividend and a dividend yield of 1.46%. CME Group’s dividend payout ratio is currently 43.99%.

In related news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of CME Group stock in a transaction on Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total value of $503,250.00. Following the transaction, the chief financial officer now directly owns 32,854 shares of the company’s stock, valued at $6,613,510.20. The disclosure for this sale can be found here. Insiders sold a total of 59,626 shares of company stock valued at $12,255,934 over the last three months. Insiders own 1.20% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Advantage Investment Management LLC increased its stake in shares of CME Group by 119.0% in the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Westside Investment Management Inc. acquired a new stake in shares of CME Group in the second quarter valued at approximately $38,000. Close Asset Management Ltd acquired a new stake in CME Group during the 1st quarter worth $34,000. Private Capital Group LLC boosted its position in shares of CME Group by 44.9% during the second quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 75 shares in the last quarter. Finally, Permanens Capital L.P. bought a new stake in CME Group in the 1st quarter valued at $41,000. Hedge funds and other institutional investors own 84.99% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: How to calculate compound interest

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Great Lakes Advisors LLC Buys 1462 Shares of CME Group Inc (NASDAQ:CME)

Great Lakes Advisors LLC boosted its position in CME Group Inc (NASDAQ:CME) by 8.3% in the 2nd quarter, according to its most recent filing with …

CME Group logoGreat Lakes Advisors LLC boosted its position in CME Group Inc (NASDAQ:CME) by 8.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,165 shares of the financial services provider’s stock after purchasing an additional 1,462 shares during the period. Great Lakes Advisors LLC’s holdings in CME Group were worth $3,721,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in CME. Independent Advisor Alliance boosted its holdings in CME Group by 5.9% in the first quarter. Independent Advisor Alliance now owns 1,947 shares of the financial services provider’s stock valued at $321,000 after acquiring an additional 108 shares during the last quarter. Fox Run Management L.L.C. acquired a new position in shares of CME Group during the second quarter worth about $571,000. Aperio Group LLC lifted its stake in shares of CME Group by 3.7% during the second quarter. Aperio Group LLC now owns 210,967 shares of the financial services provider’s stock worth $40,951,000 after purchasing an additional 7,573 shares in the last quarter. Jackson Hole Capital Partners LLC lifted its stake in shares of CME Group by 4.1% during the first quarter. Jackson Hole Capital Partners LLC now owns 1,986 shares of the financial services provider’s stock worth $327,000 after purchasing an additional 79 shares in the last quarter. Finally, KC Investment Advisors LLC lifted its stake in shares of CME Group by 9.0% during the first quarter. KC Investment Advisors LLC now owns 2,898 shares of the financial services provider’s stock worth $477,000 after purchasing an additional 240 shares in the last quarter. 84.99% of the stock is owned by institutional investors.

In other news, insider Sean Tully sold 7,200 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the completion of the sale, the insider now owns 19,923 shares of the company’s stock, valued at $4,445,418.99. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the sale, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. Insiders have sold 59,626 shares of company stock valued at $12,255,934 over the last 90 days. Corporate insiders own 1.20% of the company’s stock.

CME traded up $0.42 during trading on Friday, reaching $205.80. The stock had a trading volume of 974,804 shares, compared to its average volume of 1,132,937. The stock has a 50 day moving average of $211.25 and a two-hundred day moving average of $191.16. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $224.91. The firm has a market capitalization of $72.54 billion, a price-to-earnings ratio of 30.18, a price-to-earnings-growth ratio of 4.51 and a beta of 0.19.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The business had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the business posted $1.74 earnings per share. CME Group’s revenue for the quarter was up 20.1% compared to the same quarter last year. On average, research analysts forecast that CME Group Inc will post 6.69 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 43.99%.

CME has been the topic of a number of analyst reports. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price on the stock. in a research report on Monday, May 27th. UBS Group lifted their target price on CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a research report on Thursday, September 5th. Deutsche Bank boosted their price objective on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a report on Friday, August 9th. Barclays boosted their price objective on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday, May 23rd. Finally, BidaskClub lowered CME Group from a “buy” rating to a “hold” rating in a report on Thursday. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $196.85.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Trading Strategy Methods and Types

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Cetera Investment Advisers Has $312000 Stake in CME Group Inc (NASDAQ:CME)

Cetera Investment Advisers lifted its stake in CME Group Inc (NASDAQ:CME) by 11.5% in the 2nd quarter, according to the company in its most recent …

CME Group logoCetera Investment Advisers lifted its stake in CME Group Inc (NASDAQ:CME) by 11.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,613 shares of the financial services provider’s stock after purchasing an additional 166 shares during the quarter. Cetera Investment Advisers’ holdings in CME Group were worth $312,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Dimensional Fund Advisors LP boosted its position in shares of CME Group by 2.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 906,174 shares of the financial services provider’s stock worth $170,463,000 after buying an additional 24,717 shares during the period. Geode Capital Management LLC boosted its holdings in CME Group by 12.9% in the fourth quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock valued at $885,776,000 after purchasing an additional 537,917 shares during the period. Mercer Global Advisors Inc. ADV purchased a new position in CME Group in the first quarter valued at $304,000. Quantamental Technologies LLC acquired a new stake in CME Group in the first quarter valued at $81,000. Finally, Moors & Cabot Inc. acquired a new stake in CME Group in the first quarter valued at $204,000. 84.99% of the stock is owned by hedge funds and other institutional investors.

In other news, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 79,057 shares in the company, valued at $15,823,258.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction that occurred on Tuesday, July 9th. The shares were sold at an average price of $201.30, for a total transaction of $503,250.00. Following the completion of the transaction, the chief financial officer now owns 32,854 shares of the company’s stock, valued at $6,613,510.20. The disclosure for this sale can be found here. In the last quarter, insiders have sold 59,626 shares of company stock worth $12,255,934. 1.20% of the stock is owned by company insiders.

CME traded up $0.42 during trading on Friday, hitting $205.80. The company’s stock had a trading volume of 974,804 shares, compared to its average volume of 1,132,937. The firm’s 50 day moving average price is $211.25 and its 200-day moving average price is $191.16. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05. CME Group Inc has a twelve month low of $161.05 and a twelve month high of $224.91. The stock has a market cap of $72.54 billion, a PE ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm’s revenue was up 20.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.74 EPS. Equities analysts anticipate that CME Group Inc will post 6.69 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 annualized dividend and a yield of 1.46%. CME Group’s dividend payout ratio (DPR) is 43.99%.

CME has been the topic of a number of analyst reports. Wells Fargo & Co raised their price target on CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research note on Wednesday, July 3rd. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a research report on Thursday. UBS Group raised their price target on CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a report on Thursday, September 5th. Deutsche Bank raised their price target on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Finally, Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective on the stock. in a report on Monday, May 27th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $196.85.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: How do taxes affect a CDs total return?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

CME Group Inc (NASDAQ:CME) COO Julie Holzrichter Sells 3436 Shares

CME Group Inc (NASDAQ:CME) COO Julie Holzrichter sold 3,436 shares of the company’s stock in a transaction that occurred on Tuesday, …

CME Group logoCME Group Inc (NASDAQ:CME) COO Julie Holzrichter sold 3,436 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $216.07, for a total value of $742,416.52. Following the completion of the sale, the chief operating officer now owns 38,704 shares of the company’s stock, valued at $8,362,773.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Shares of NASDAQ CME traded up $0.42 during midday trading on Friday, reaching $205.80. 974,804 shares of the company were exchanged, compared to its average volume of 1,132,937. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. The stock has a market cap of $72.54 billion, a P/E ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19. CME Group Inc has a 1 year low of $161.05 and a 1 year high of $224.91. The stock has a fifty day simple moving average of $211.25 and a 200 day simple moving average of $191.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter last year, the firm earned $1.74 earnings per share. The firm’s revenue was up 20.1% compared to the same quarter last year. As a group, analysts forecast that CME Group Inc will post 6.69 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be given a dividend of $0.75 per share. The ex-dividend date is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.46%. CME Group’s payout ratio is 43.99%.

Several hedge funds have recently bought and sold shares of the company. Nuveen Asset Management LLC raised its position in shares of CME Group by 18,355.3% during the 2nd quarter. Nuveen Asset Management LLC now owns 3,238,530 shares of the financial services provider’s stock worth $628,631,000 after purchasing an additional 3,220,982 shares during the last quarter. Parnassus Investments CA purchased a new stake in CME Group in the 2nd quarter worth approximately $544,292,000. Magellan Asset Management Ltd purchased a new stake in CME Group in the 2nd quarter worth approximately $418,297,000. Geode Capital Management LLC grew its stake in CME Group by 12.9% in the 4th quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after acquiring an additional 537,917 shares during the period. Finally, Fiera Capital Corp grew its stake in CME Group by 17.0% in the 2nd quarter. Fiera Capital Corp now owns 2,960,477 shares of the financial services provider’s stock worth $574,658,000 after acquiring an additional 429,235 shares during the period. Institutional investors own 84.99% of the company’s stock.

A number of research analysts have commented on CME shares. Wells Fargo & Co upped their price target on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research note on Wednesday, July 3rd. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target on the stock. in a research note on Monday, May 27th. Deutsche Bank increased their price objective on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Barclays increased their price objective on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research note on Thursday, May 23rd. Finally, UBS Group increased their price objective on CME Group from $191.00 to $214.00 and gave the company a “neutral” rating in a research note on Thursday, September 5th. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the company. CME Group currently has a consensus rating of “Hold” and an average target price of $196.85.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: How Do Front-End Loads Impact an Investment?

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts